News – Page 390 – Endpoints News

#JPM23: Fireside chat with Barry Greene: 'There's no straight line to success'

3 years ago

After Lilly complaint, Novartis pulls claim in DTC cancer drug ad

3 years ago

TheracosBio aims to challenge Big Pharma blockbusters with newly-approved SGLT2 for diabetes

3 years ago

Pliant posts high-dose data of oral IPF drug with 'quite favorable' safety, outlines trial plans

3 years ago

On orphan drug exclusivity, FDA decides to go its own way after court loss

3 years ago

Over 130 employees let go from Merck KGaA R&D teams in Massachusetts

3 years ago

Iovance picks up IL-2 Proleukin for $200M+ upfront; Estrella Biopharma to wait for SPAC deal finish

3 years ago

FDA will consult outside advisors on whether Biogen’s ALS drug can be approved on a biomarker

3 years ago

VC investor Paul Manning donates $100M to UVA for new R&D institute

3 years ago

#JPM23: When will the IPO window open? What terms are startups getting? Here's what to expect from capital markets ...

3 years ago

FDA hopes to simplify and standardize Covid shots without making them interchangeable

3 years ago

Alvotech raises $137M months after FDA rejected Humira biosimilar

3 years ago

Updated: J&J axes four-year discovery alliance with Morphic

3 years ago

Updated: Takeda bets $400M cash on colorectal cancer drug in boost to China's Hutchmed

3 years ago

What’s with Bristol Myers’ R&D job cuts in New Jersey? They’re not saying much

3 years ago

An Alzheimer’s rejection; Our #JPM23 dispatches; Count Moderna in for RSV; Biotech layoffs persist; and more

3 years ago

Sanofi, AbbVie, MSD pledge with Publicis and consumer brand cohort to end cancer stigma at work

3 years ago

UK's NICE stamps approval on Alnylam, PTC rare disease drugs

3 years ago

Next-gen mpox treatments: FDA calls for diverse, randomized controlled trials

3 years ago

Sanofi promises money back for discontinued blood disorder treatment – in some cases

3 years ago

Israel, EU drug regulators find no link between Pfizer Covid shot and stroke

3 years ago

AstraZeneca expands chronic kidney disease 'Target' campaign for Farxiga

3 years ago

'Blue Brain Boost': FDA blocks Colorado couple from importing and reselling drugs from China

3 years ago

Federal judge upholds Cabometyx patent in Exelixis' generic battle

3 years ago

First page Previous page 387 388 389390391 392 393 Next page Last page